Prevail helps life sciences companies achieve better clinical trial outcomes through groundbreaking yet affordable smart technologies, domain intelligence, and expert services that illuminate and improve every aspect of your trial.
Download the Prevail InfoWorks corporate brochure
View our short video to get an overview of how Prevail InfoWorks is helping our customers deliver better outcomes.
In an interview with MedCity News, Aurinia Pharmaceuticals talks about how Prevail InfoWorks helps improve clinical development.
Download the article
Prevail’s innovative analytics provide timely, data-driven insights into live studies, regardless of protocol, data, and system complexity – all without breaking the blind. Improve study success with early observations of aggregated data across your studies and programs.
Download the Prevail InfoWorks analytics data sheet
Discover how researchers with timely, direct access to high-value visualizations and early observations across every aspect of their studies were able to achieve the first-ever FDA approval in a challenging indication – while saving time, effort, and cost.
Download the case study
Prevail’s eTMF provides a paperless and automated system for collecting essential documents, while helping identify gaps and manage workflow processes across multiple team members and functional groups in real-time.
Download the Prevail InfoWorks eTMF data sheet
Prevail’s patented RTSM technology platform delivers fast, accurate, and controlled randomization and trial supplies management while keeping your budget in check.
Download the Prevail InfoWorks RTSM data sheet
Our innovative and modular safety system makes safety and risk management easy, compliant, and affordable for any life sciences company.
Download the Prevail InfoWorks Safety System data sheet
Watch this expert presentation to hear valuable lessons learned and case studies on making decentralized clinical trials successful.
Discover how Prevail’s unique RTSM technology and expert services have helped overcome even the most complex trial supply challenges – complicated further by the global pandemic.
In this case study webinar, you will discover how a North American pharmaceutical company’s innovative development program for an autoimmune disease treatment succeeded, when more than 30 drugs from other sponsors for the same indication had failed.